PCNA and lung cancer: F. persica and its main constituent coumarin are shown as a possible treatment for lung cancer via the inhibition of cyclins and CDK, their reducing effects on cancer cell migration and metastasis mediated by cytokines such as IL‐1β, oxidative marker production, cell viability and cytotoxicity.